Healthcare M&A Deal Facilitation and Protection - Polsinelli
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Healthcare elists M&A Deal Facilitation and Protection Mat Allen Linda Jones Jon Henderson Marsh USA Marsh USA Polsinelli, PC Transactional Risk Healthcare Chair, Corporate and Transactional Practice Group Co-Lead, Healthcare M+A Practice MARSH
Agenda • Strategic Healthcare Deal Facilitation and Protection • Transactional Risk Insurance Overview – Representations & Warranties Insurance – Tax Indemnity Insurance – Contingent Liability Insurance • Claims Data and Protection • Key Strategies for Deal Acceleration • Healthcare Specific Applications MARSH 2
Polsinelli’s Healthcare M&A Practice 2020-Q1 2021 96 Health Care Deals 24 Health Care Deals 50% Buy-Side Representation in 2020 Totaling in Q1 2021 Totaling $3.4B $2.8B 50% Sell-Side Representation Buy-Side Most Active Sectors Number of Deals Sell-Side Most Active Sectors Number of Deals Hospitals and Health Systems 7 Hospitals and Health Systems 10 Optometry 7 Dental 7 Physician Groups 6 Skilled Nursing, Assisted Living and Behavioral and Mental Health 5 Senior Care 2 Infusion Therapy 5 Medical Equipment and Supplies 4 Clinics and Outpatient Centers 2 Home Health and Hospice 4 Behavioral and Mental Health 2 MARSH 4
Deal Facilitation & Protection • Traditional Strategies • Historical Hurdles for the Healthcare Industry – Medicare – Medicaid • Where Transactional Risk Works Well • New Healthcare Adopters MARSH 5
TRANSACTIONAL RISK INSURANCE OVERVIEW 6
Transactional Risk Insurance Overview Created to facilitate M&A transactions by addressing indemnification issues that arise during the negotiation of the transaction or during due diligence that may prevent the deal from signing: • Representations and warranties insurance • Tax indemnity insurance • Contingent liability insurance Transactional risk insurance is used to protect or mitigate two types of risks that typically arise from M&A transactions: Representations and warranties insurance Unknown and - Buyer-side policy unforeseen loss - Seller-side policy Identified tax issues Identified and known risks Other contingent risks (e.g., successor liability) MARSH 7
Transactional Risk Insurance Overview Significant growth in North America during past decade 2020 - $19.59 billion in limits / 584 closed deals North America Market Statistics for Marsh only 700 $25,000 2019 - $19.55 billion in limits / 526 closed deals 2018 - $13.75 billion in limits / 405 closed deals 600 2017 - $8.83 billion in limits / 303 closed deals $20,000 500 2016 - $6.03 billion in limits / 212 closed deals 2015 - $4.26 billion in limits / 159 closed deals $15,000 400 2014 - $2.73 billion in limits / 130 closed deals Limits Placed ($ in millions) 2013 - $1.34 billion in limits / 66 closed deals 300 Deal Volume $10,000 2012 - $1.43 billion in limits / 51 closed deals 200 2011 - $767 million in limits / 45 closed deals $5,000 2010 - $387 million in limits / 25 closed deals 100 0 $- MARSH 8
Transactional Risk – 2020 Deals by Industry Sector • Health Care – 17 deals through 1stQ 2021, 36 deals in 2020 Deal Count By Industry 0 20 40 60 80 100 120 140 160 180 Communications, Media, and Technology 159 Manufacturing and Automotive 86 Retail, Wholesale, Food, and Beverage 48 Financial Institutions 37 Health Care 36 Professional Services 33 Life Sciences 29 Energy, Power, and Utilities 28 Other Services 24 Chemical 19 Construction 17 Transportation and Rail 13 Education 9 Agriculture, Forestry, and Fisheries 9 Sports, Events, and Entertainment 6 Aviation and Aerospace 5 Real Estate 5 Marine 4 Misc. Other 17 MARSH 9
Transactional Risk Insurance Overview The transactional risk insurance market has continued to evolve in recent years and can provide more innovative insurance solutions than ever The market now offers: Global Market Statistics for 2019 (Marsh only) • Broader coverage US$ AMERICAS EMEA ASIA PACIFIC TOTAL • Streamlined process Limits of • Increased limits of liability insurance placed 19,555,000,000 25,375,000,000 5,955,000,000 50,885,000,000 ($) • Reduced premium rates No. of closed 526 592 123 1,241 transactions and deductible levels Private equity policies (as % of 51% 54% 42% 51% Marsh has an estimated policies placed) Corporate policies 25% global market share (as % of policies 49% 46% 58% 49% placed) Seller-side R&W Marsh placed over 1,700 policies (as % of 1% 3% 6% 2% R&W policies Transactional Risk policies placed) Buyer-side R&W globally in 2019 policies (as % of 99% 97% 94% 98% R&W policies placed) MARSH 10
REPRESENTATIONS & WARRANTIES INSURANCE MARSH 11
Reps & Warranties Insurance Overview Provides coverage for financial losses resulting from breaches of representations and warranties made by target company or sellers contained in purchase agreement • Protects an insured from unanticipated (unknown) losses that may arise subsequent to the closing • Reps & warranties insurance generally covers all reps & warranties in the purchase agreement • Either buyer or seller can be the insured under the policy Reps & Warranties Insurance: Typical Uses Buyers Sellers • Increase maximum indemnity / • Reduce contingent liabilities enabling distribution extend survival period for breaches of sale proceeds of reps & warranties • Include R&W insurance as the sole • Provide recourse when no seller remedy in draft agreements in auctions indemnity possible • Attract best offers by maximizing indemnification • Distinguish bid in auction • Protect passive sellers • Protect key relationships • Elimination of seller post-closing credit risk MARSH 12
Reps & Warranties Insurance: Policy Considerations Policies generally survive for longer periods than in the Duration of Policy underlying acquisition agreement (3 years for general reps / 6 years for tax and fundamental reps) Total costs are typically 4% +/- of the policy limit (one-time Cost and Coverage Limits payment; % may be lower for larger deals), including premium, taxes, underwriting fees and broker compensation Retentions on R&W policies are typically 1% of enterprise Retention / Deductible value (lower for large deals) and normally drop down to 0.5% of enterprise value at 12-month anniversary of Closing Carriers are typically willing to be silent with respect to Definition of Loss consequential and multiplied damages (as opposed to having exclusions for those types of damages) Carriers are typically willing to recognize materiality scrapes Materiality Scrape for purposes of determining the existence of a breach of a rep and losses related thereto Policies contain “Actual Knowledge” exclusion and exclusions Exclusions for forward looking statements, working capital adjustments, asbestos and PCBs, and pension underfunding/withdrawal, NOL’s/deferred tax assets and transfer pricing MARSH 13
Reps & Warranties Insurance: Policy Considerations Generally limited to actual conscious awareness (no constructive or Definition of Knowledge imputed knowledge), with no duty to inquire and the carrier having the burden of proving knowledge Carriers will waive their subrogation rights against the sellers except Seller Subrogation in instances of fraud Carriers may agree to limit their subrogation rights against customers Other Subrogation and suppliers (e.g., no subrogation against customers or suppliers until losses against such parties exceed a specified threshold amount) For small settlements by the insured and/or settlements by the Settlements insured within the retention, carriers may agree to waive their consent rights Policies may contain a safe harbor provision, only permitting the Failure to Comply carrier to deny coverage to the extent that the carrier is actually/materially prejudiced by an insured’s failure to comply Carriers are typically willing to bind coverage at signing subject to an Signing vs. Closing exclusion from coverage of interim breaches MARSH 14
Reps & Warranties Insurance: Heightened Risk Areas Certain reps & warranties are more difficult to insure and may be addressed through increased due diligence, additional premium, or exclusions • COVID-19 • Cyber security/data privacy • Products Liability • Environmental • Wage and hour laws • Healthcare (Medicare and Medicaid billing) – Requires a 3rd party audit of ~ 100 claims MARSH 15
Reps & Warranties Insurance: Underwriting Process Days 1 – 2 Engage broker (earlier in the process is better) Note: Insurers need to understand exclusivity Broker and potential underwriters execute NDAs arrangements on transaction (or lack thereof) – timing / financial impact on process Days 3 – 6 Obtain quotes from underwriters • In order to get quotes, we need recent draft acquisition agreement, information memorandum and target’s financials • No cost to obtain quotes Day 6 Select underwriter • Broker to discuss pros and cons of proposals • Insurer diligence fee becomes payable upon entering underwriting ($25K – $40K) 1 2 3 4 5 6 7 8 9 10 11 12+ Days 6 to 12+ Underwriting of policy • Underwriter to gain access to data room and legal, financial, tax and other diligence reports (subject to non-reliance letters) • Conference call with deal team and advisors Policy negotiations • Done in parallel with underwriting; outside counsel typically involved MARSH 16
Myth vs Reality • R&W Insurance will slow the process - 4 days to obtain a quote and 5-7 days to finalize the insurance by signing. • Too expensive – Cost can be paid for by seller or split by buyer and seller. • Exclusions – only based on know items that should be included as exceptions/scheduled to reps or based on lack of diligence. – Ability to remedy. Auction vs. Exclusive. • Deal Size – Can do deals as small as $25mm in EV. • Every deal needs insurance – Not necessarily for exclusive deals with financially strong indemnity. ~ 80% of PE transactions and ~ 65% PE to Strategic. MARSH 17
Reps & Warranties Insurance: State of the Market Increased popularity and well-developed market • 2,000+ deals completed annually in North America (split between corporate and PE buyers) • Insurers / brokers staffed by former attorneys – work on deal timeframes • International capabilities Target transactions and market trends • Transactions between $25M – $5B+ • Limits available - $1B+ per transaction • Generally no restrictions on industry sector • Current market trends Insurer commitment MARSH 18
TAX INSURANCE MARSH 19
Tax Insurance: Overview Coverage Insures against the financial consequences of an intended tax treatment being disallowed by relevant tax authority in situations where: • There is no clear precedence or guidance • Transaction economics flowing to parties relies heavily on the tax structure such that investors and/or lenders thereto require comfort that the tax structure and benefits will be respected • Tax authority approval (e.g., PLR) is not available or cannot be received in required time frame • Potential downside is significant relative to transaction size and the financial model does not allow for “margin for error” Tax Liability Insurance Tax Indemnity Insurance • Tax Opinion Insurance: Insure the conclusion of a tax • Typically occurs in M&A context opinion or filing position for a specific transaction or • Known tax risks and certain tax attributes are excluded event from traditional R&W policy • Tax Return Insurance: Insure some or all positions on a • Backstops/replaces tax indemnity in SPA tax return of a specific taxable period • A separate tax insurance policy provides a holistic insurance solution Common Issues • 355 spin-offs • Tax free reorganizations • Liquidating trust status • 338(h)(10) elections/S-Corp issues • NOL protection • Capital gain v. ordinary income treatment • Debt/equity characterization • Tax credits • REIT status • Cancellation of indebtedness • Successor liability 20 MARSH
CONTINGENT LIABILITY INSURANCE MARSH 21
Contingent Liability Insurance Contingent liability insurance covers “one-off” identified potential exposures that have not yet crystallized Recent examples • Successor liability • Specific indemnities • Fraudulent conveyance • Other legal, legislative or regulatory risks Three things necessary to insure a risk: • Quantifiable risk • Probability analysis • No moral hazard Cost, limits and deductibles vary based on the particular risk MARSH 22
Claims Data and Protection MARSH April 20, 2021 23
Frequently Made Claims Representations relating to financial statements, compliance with laws, material contracts and taxes are the most frequently alleged to have been breached Source: 2020 AIG Claims Study MARSH 24
Timing of Claims More than half of all claim notices are received within the first 12 months of the policy’s issuance Source: 2020 AIG Claims Study MARSH 25
Healthcare M&A 2021 and Beyond Key Strategies for Deal Acceleration MARSH April 20, 2021 26
2021 & Beyond • Where We’re Headed • How We Think About the Indemnification Package MARSH 27
Healthcare Specific Applications MARSH April 20, 2021 28
Deal Facilitation & Protection • Current State • Potential Future State • Key Considerations MARSH 29
This document and any recommendations, analysis, or advice provided by Marsh (collectively, the “Marsh Analysis”) are intended solely for the entity identified as the recipient herein (“you”). This document contains proprietary, confidential information of Marsh and may not be shared with any third party, including other insurance producers, without Marsh’s prior written consent. Any statements concerning actuarial, tax, accounting, or legal matters are based solely on our experience as insurance brokers and risk consultants and are not to be relied upon as actuarial, accounting, tax, or legal advice, for which you should consult your own professional advisors. Any modeling, analytics, or projections are subject to inherent uncertainty, and the Marsh Analysis could be materially affected if any underlying assumptions, conditions, information, or factors are inaccurate or incomplete or should change. The information contained herein is based on sources we believe reliable, but we make no representation or warranty as to its accuracy. Except as may be set forth in an agreement between you and Marsh, Marsh shall have no obligation to update the Marsh Analysis and shall have no liability to you or any other party with regard to the Marsh Analysis or to any services provided by a third party to you or Marsh. Marsh makes no representation or warranty concerning the application of policy wordings or the financial condition or solvency of insurers or reinsurers. Marsh makes no assurances regarding the availability, cost, or terms of insurance coverage. MA13-12658 Copyright © 2019 Marsh Inc. All rights reserved MARSH 30
You can also read